CDSCO

Vaccinated but Stuck: Indians Await WHO Nod for Homegrown Shot To Travel Abroad

Expert Panel Recommends Emergency-Use Okay for Covaxin in 2-18 Age Group

India Allows Serum Institute to Enrol 7-11 Year Olds in COVID Vaccine Trial

COVID-19: Small, Preliminary Study Doesn’t Find Proof of AYUSH 64’s Efficacy

CDSCO Expert Panel Gives Nod to Study on Mixing Doses of Covaxin, Covishield

Sputnik V Second Dose Shortage To Delay India’s Full Rollout: Dr Reddy’s

India Refuses Emergency Use License for One-Dose Sputnik